tadalafil has been researched along with thioguanine anhydrous in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (thioguanine anhydrous) | Trials (thioguanine anhydrous) | Recent Studies (post-2010) (thioguanine anhydrous) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 2,706 | 295 | 389 |
| Protein | Taxonomy | tadalafil (IC50) | thioguanine anhydrous (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.5333 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.601 | |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | 5.516 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for tadalafil and thioguanine anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |